Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice

Didier Cataldo, Eric Derom, G. Liistro, Éric Marchand, Vincent Ninane, Rudi Peché, H. Slabbynck, Walter Vincken, Wim Janssens

Résultats de recherche: Contribution à un journal/une revueArticle de revueRevue par des pairs

46 Téléchargements (Pure)


Evidence and guidelines are becoming increasingly clear about imbalance between the risks and benefits of inhaled corticosteroids (ICSs) in patients with COPD. While selected patients may benefit from ICS-containing regimens, ICSs are often inappropriately prescribed with – according to Belgian market research data – up to 70% of patients in current practice receiving ICSs, usually as a fixed combination with a long-acting β2-adrenoreceptor agonist. Studies and recommendations support withdrawal of ICSs in a large group of patients with COPD. However, historical habits appear difficult to change even in the light of recent scientific evidence. We have built a collaborative educational platform with chest physicians and primary care physicians to increase awareness and provide guidance and support in this matter.
langue originaleAnglais
Pages (de - à)2089-2099
Nombre de pages11
journalInternational Journal of COPD
Date de mise en ligne précoce2018
Les DOIs
Etat de la publicationPublié - 2018

Empreinte digitale

Examiner les sujets de recherche de « Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation